Cyclacel Pharmaceuticals, Inc.

CYCCNASDAQHealthcare

$6.37

$-0.41(-5.98%)

Market Cap$10608329

P/E Ratio—

52W High$597.59973

52W Low$3.0801

Avg Volume1.8M

Open$6.76

Beta0.16

Employees Ownership Insider Trades

Cyclacel Pharmaceuticals, Inc. (CYCC) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · CYCC · as of Mar 30, 2026

Latest filing snapshot

+19—vs prior year

Cyclacel Pharmaceuticals, Inc. (CYCC) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

Change (1Y)

+19

Growth % (1Y)

—

Revenue / Employee

$39.3K

Net Income / Employee

$-157.8K

Market Cap

$11M

CYCC Employee Count

2004 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-30	2025-12-31	19	+19	—
2025-04-02	2024-12-31	0	+0	—
2024-03-21	2023-12-31	0	+0	—
2023-03-08	2022-12-31	0	+0	—
2022-03-30	2021-12-31	0	+0	—
2021-03-01	2020-12-31	0	-12	-100.00%
2020-03-05	2019-12-31	12	-2	-14.29%
2019-03-28	2018-12-31	14	+2	+16.67%
2018-03-30	2017-12-31	12	-1	-7.69%
2017-03-31	2016-12-31	13	-3	-18.75%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

Gelesis Holdings, Inc.

Cyclacel Pharmaceuticals, Inc.YOU

19$11M #6

AMTI

Applied Molecular Transport Inc.

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · CYCC peer comparison

About CYCC employees

CYCC Employees · Headcount

Cyclacel Pharmaceuticals, Inc. (CYCC) employee data is sourced from the annual SEC 10-K filing. As of 2025, Cyclacel Pharmaceuticals, Inc. had 19 full-time employees globally. Full-time employees only. Global consolidated headcount.

Cyclacel Pharmaceuticals, Inc. employs 19 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $39,316, reflecting the company's operational efficiency.

Cyclacel Pharmaceuticals, Inc.'s workforce increased by 19 (0.00%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Cyclacel Pharmaceuticals, Inc.'s revenue per employee of $39,316 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

CYCC Employees · 5 questions

As of the latest SEC 10-K filing (2025), Cyclacel Pharmaceuticals, Inc. had 19 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Cyclacel Pharmaceuticals, Inc. employee counthow many employees does Cyclacel Pharmaceuticals, Inc. haveCYCC total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-30